TERIFLUNOMIDE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,320 adverse event reports in the FDA FAERS database where TERIFLUNOMIDE was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for TERIFLUNOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alopecia | 5,441 | 13.9% | 28 | 611 |
| Multiple sclerosis relapse | 4,745 | 12.1% | 39 | 1,012 |
| Fatigue | 4,257 | 10.8% | 39 | 692 |
| Diarrhoea | 4,175 | 10.6% | 46 | 680 |
| Fall | 2,878 | 7.3% | 41 | 771 |
| Hypoaesthesia | 2,851 | 7.3% | 24 | 540 |
| Headache | 2,651 | 6.8% | 24 | 435 |
| Paraesthesia | 2,472 | 6.3% | 19 | 416 |
| Drug ineffective | 2,469 | 6.3% | 16 | 250 |
| Nausea | 2,311 | 5.9% | 34 | 464 |
| Gait disturbance | 2,074 | 5.3% | 27 | 572 |
| Pain | 1,985 | 5.1% | 21 | 467 |
| Multiple sclerosis | 1,983 | 5.1% | 24 | 337 |
| Condition aggravated | 1,796 | 4.6% | 20 | 392 |
| Depression | 1,612 | 4.1% | 18 | 283 |
Other Indications for TERIFLUNOMIDE
Multiple sclerosis (29,963)
Product used for unknown indication (1,438)
Multiple sclerosis relapse (216)
Illness (153)
Relapsing multiple sclerosis (111)
Secondary progressive multiple sclerosis (37)
Demyelination (19)
Rheumatoid arthritis (19)
Migraine (18)
Ill-defined disorder (17)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
RITUXIMAB (956)
TECFIDERA (806)